Patent · US Active

Pyrazine kinase inhibitors

US9359308B2 · kind B2 · utility

0Cited by
101References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 23, 2012
Grant dateJun 7, 2016
Priority date
Expiry dateNov 23, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are pyrazine compounds of Formula (I)for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibition Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.